Clinical and industry attendees return to in-person conferences but product launches were limited.

It has been more than two years since the last in-person Society for Advancement of Wound Care (SAWC) meeting and based on attendance at this year’s meeting in Las Vegas (October 29-31), wound care clinicians and exhibitors were ready to be live and in person again.

SmartTRAK returned to the conference in person too and walked the exhibit floor, attended symposia and talked to exhibitors and clinicians to understand the latest trends in the US market for Advanced Wound Care, which is projected to reach
* by 2025E according to SmartTRAK estimates. Two dominant takeaways emerged from SAWC Fall 2021, including the enthusiastic return of in-person wound conferences and only a limited selection of new product introductions.

Pete Wehrly, CEO of VIVEX Biologics, discusses the Company and its diverse portfolio in orthopedics and wound care in an interview with SmartTRAK

In an interview with SmartTRAK, VIVEX Biologics’ CEO Pete Wehrly discusses how VIVEX’ diverse portfolio of regenerative solutions in orthopedics and wound care can potentially turn the regenerative medicine industry on its ear with an eye towards proving, through economic and clinical evidence, that its technologies are better than anything on the market today.

To find out more about the Company, its technologies and what’s next in terms of clinical research and reimbursement, click on the following video to see the interview recorded live at the North American Spine Society (NASS) Annual Meeting held in Boston Sept 29 to Oct 2, 2021 (11:24 min). A link to download the complete transcript of the interview is also provided below.

In an interview with SmartTRAK, Parachute Health CEO David Gelbard discusses the Company and its novel, online DME ordering system for medical devices and supplies that benefit the patient, provider and supplier eliminating the challenges of the ancient fax world.

Parachute Health has implemented a novel, online ordering system that is used for a variety of DME supplies including mobility, sleep therapy and respiratory aids, along with diabetes, wound care, ostomy and urology incontinence supplies. The system benefits the patient, provider and supplier by creating a win, win, win for all and eliminates the challenges of the back-and-forth approval process associated with faxing requests.

In an interview with SmartTRAK, Parachute Health’s CEO, David Gelbard said he founded the Company because his father did not receive an important DME supply after leaving the hospital, causing him to fall at home and requiring additional care. David’s vision for the Company is to establish the infrastructure for DME supplies such that its ease-of-use replicates that of ordering shoes on Amazon or swiping your credit card at a local coffee store. Today, the Company operates across the US at 40,000 different sites of care, from hospitals, nursing homes and doctor’s offices to home health and hospice agencies, and has a network of over 100,000 physicians and prescribers—a number that is rapidly growing. To find out more about the Company and its operation, click on the following video to listen to SmartTRAK’s interview with David Gelbard, recorded via Uberconference (23:35 min). A link to the complete transcript of the interview is also provided below.

It's time to get out there again and reconnect. SmartTRAK is excited to be attending SAWC Fall, the Symposium on Advanced Wound Care in Las Vegas, Nevada, October 29-31. Gary Delhougne, our new GM,  Wound, will be representing SmartTRAK at the meeting. Please reach out if you would like to meet with Gary in Nevada and see what SmartTRAK can do for you. We've also put together an overview of the latest AWC news to give you a little head start before you get to Vegas.

At SmartTRAK, we constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, patents, trends, new products, financial data and competitor developments in the global Life Sciences industry. The following is just a small sampling of recent Advanced Wound Care related news and updates from around the world compiled, reviewed and posted in real time every day by the expert analysts at SmartTRAK.

Markets:

• Advanced Medical Solutions*
  

  AMS announced that they became part of the NHS Shared Business Services (NHS SBS) framework in the UK w/ their range of advanced wound care dressings. The agreement covers health and corporate services including, e.g., IT, legal, estates & facilities and business services.

• Foam Dressings in Europe
  Foam is the leading dressing category in the TOP5 EU countries except for Italy, where antimicrobial dressings head up the market in 2020. France owns 36% of the EU Foam market followed by Germany w/ 22%, UK w/ 14%, Spain w/ 8% and Italy w/ 3%. SmartTRAK Europe Market Reports 
  
  
• Winner Medical*
  Winner Medical reported from their participation in the 85th China International Medical Equipment (Autumn) Expo (CMEF) in Shenzhen, China. Winner exhibited their market areas, mainly wound care and infection prevention, for professional care and home care.<
  

We are pleased to announce that Gary Delhougne has joined the team at SmartTRAK as General Manager, Wound. Gary is a licensed attorney with 20 years’ medical device and consulting experience in market access, health economics and policy roles at Smith & Nephew, Covidien, Avalere Health and Ernst & Young.

Gary will be taking over for Susan Paquette, who is retiring at the end of the year. For the past 10 years, Susan has been the face of SmartTRAK Wound Care at industry meetings and has become a trusted advisor to many of our subscribers.

Gary will be representing SmartTRAK at SAWC Fall in Las Vegas, October 28-31. If you would like to meet with him to discuss the exciting new innovations ahead and learn how to network your entire organization with SmartTRAK, click the link below. To learn more about Gary, just keep reading!

Meet Gary Delhougne:

What is your role with SmartTRAK? As the General Manager of SmartTRAK’s Wound business, it is my role to lead the wound care team in delivering actionable business intelligence and decision-making tools to help our customers better serve patients and providers.

A big boost in Q2 with double-digit gains in all segments.

The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.

Among the many topics covered in detail in our comprehensive Q221 US Infection Prevention - Vascular Access Adjunct Products Market Recap* are:

Advanced Wound Care saw a strong recovery against a weak comparator.

For Q221, according to SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up, with all segments showing increases,

The US Wound Biologics market, comprising the vast majority of the global biologics market, includes the very competitive skin substitute or CTP (Cellular and/or Tissue-Based Products) market, the Topical Drug/Delivery category and Collagen Dressings. For Q221, the US market was up significantly, with CTPs accounting for the largest share, driven by Organogensis' substantial YoY gains. 

Among the many topics covered in detail in our comprehensive Q221 Advanced Wound Care Market Recap* are:

Changing market dynamics over the past ten years has not held back the robust Skin Substitute/CTP market.

As SmartTRAK celebrates its 10-year anniversary covering AWC and the Biologics area, we look back at the market drivers, products and players to see how the US Skin Substitute market has changed over the last decade. We also look ahead to see what is in store for the Skin Substitute market, which is projected to reach $1.64B in 2025E.

The following is a preview of our Wound Biologics market retrospective. The full article, available on SmartTRAK, features our industry experts discussing and analyzing these changes and trends in detail.

A return to positive growth for the quarter, but gains lag behind pre-COVID-19 levels.

The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.

Among the many topics covered in detail in our comprehensive Q121 US Infection Prevention - Vascular Access (VA) Adjunct Products Market Recap* are:

Advanced Wound Care begins to stabilize as in-person visits increase and elective procedures rebound.

For Q121, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up +6.2%, boosted by a strong performance in Biologics, with 3M maintaining the number one position in the AWC space.

Among the many topics covered in detail in our comprehensive Q121 AWC Market Recap* are: